Congress·In Committee·S. 3729

Medicare: Study on Pharmacy Middlemen and Drug Costs

PBM Reporting Transparency Act

Legislative Progress

Senate

House

President

Law

This bill, introduced by Mr. Warner and a group of bipartisan senators, requires a deep dive into how "pharmacy benefit managers" work with Medicare. These companies act as middlemen who negotiate drug prices between insurance plans and pharmacies.
The goal is to find out how secret deals between these middlemen and insurance companies affect what seniors pay out of their own pockets for medicine. It also looks at whether these deals are making it harder for local pharmacies to stay in business by changing how much they get paid.
An independent advisory group will create two major reports for Congress. These reports will look for trends in drug pricing and provide specific recommendations on how to fix problems that make healthcare more expensive for regular people.
The first report will be finished about two years after the government provides the necessary data, with a follow-up report two years later. This helps Congress see if drug costs and middleman practices are getting better or worse over time.

2 milestones2 actions

Jan 29, 2026Senate

Read twice and referred to the Committee on Finance.

Jan 29, 2026

Introduced in Senate

Document Type

Congressional Bill

Official Title

PBM Reporting Transparency Act

Bill NumberS 3729

Congress119th Congress

ChamberSenate

Latest ActionRead twice and referred to the Committee on Finance.

(3)

D: 1R: 2

Congress.gov

Official legislative information

Analysis generated by AI. Always verify with official sources.